leadf
logo-loader
viewEpsilon Healthcare Ltd
(
ASX:EPN
)

Full interview: THC Global Group granted GMP Licence for Southport cannabis facility

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA).

This milestone completes all licences required for THC Global to commence commercial manufacture of pharmaceutical medicinal cannabis.

Production at the facility on the Gold Coast began in early December.

The company also recently signed a supply agreement with MGC Pharmaceuticals Ltd for the supply of formulated medicinal cannabis products for Australian patients and the global export market.

READ: THC Global is all licensed up and ready to go: MST Access

Quick facts: Epsilon Healthcare Ltd

Follow
ASX:EPN

Price: 0.15 AUD

Market Cap: $28.91 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

PyroGenesis Canada says it has received a $6M plasma torch order with major...

PyroGenesis Canada Inc CEO Peter Pascali tells Proactive the group has received an order to supply four high-powered plasma torches together with ancillary equipment to a client (Client B) for about $6 million. Pascali says Client B is a multi-billion-dollar international producer of iron...

1 hour, 25 minutes ago

2 min read